RN
Reunion Neuroscience, Inc.
SEC filingPharmaceuticals · Morristown, NJ
Amount raised$119.9Msold at filing
Total offering$119.9M
Investors in the raise9count reported to the SEC
FiledSep 9, 2025first sale Jan 12, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Gregory MayesExecutive Officer, Director
Michael EhlersDirector
Ansbert GadickeDirector
Natalie SacksDirector
Ellen LubmanDirector
Mark PollackExecutive Officer
Alon LazarusDirector
Nathan BrysonExecutive Officer
Mark TheeuwesExecutive Officer
Edward SmithExecutive Officer
Executive officers, directors and promoters as listed on the Form D.